Bolden Therapeutics
Business Services · Rhode Island, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
225 Dyer St Fl 2, Providence, Rhode Isla...Website
www.boldentherapeutics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Bolden Therapeutics
Bolden Therapeutics is a biotechnology company focused on developing first-in-class therapeutics aimed at promoting neurogenesis to improve outcomes for individuals suffering from neurological diseases. Their innovative approach targets specific signaling pathways to enhance the formation of new brain cells, with potential applications in conditions such as Alzheimer's disease, stroke recovery, and treatment-resistant depression. The company is advancing multiple therapeutic modalities, including exon-skipping antisense oligonucleotides, to address cognitive dysfunction and memory impairment. Bolden Therapeutics is committed to transforming the treatment landscape for various CNS illnesses through their groundbreaking research and development efforts.Explore more
Bolden Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Bolden Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Bolden Therapeutics
Check if Bolden Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Bolden Therapeutics recently announced quarterly report
Bolden Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Bolden Therapeutics had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Bolden Therapeutics has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Bolden Therapeutics is spiking on competitors!
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Bolden Therapeutics launches new products
Recommended Actions
Reach out to Masked Content who joined Bolden Therapeutics as Masked Content
Find 2 more new buyers
Compare Similar Companies to Bolden Therapeutics
Compare insights from companies similar to Bolden Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Bolden Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Bolden Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Bolden Therapeutics.
Bolden Therapeutics financials insights
Gather financial insights about Bolden Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Other Financing Round
$1.5M
Bolden Therapeutics Tech Stack
A closer look at the technologies used by Bolden Therapeutics
Most Recent Scoops
Funding
Project
Spending/Investment, Funding
Funding
Funding
Event
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Bolden Therapeutics
Sign Up For FreeTo access detailed company insights
Bolden Therapeutics is a biotechnology company focused on developing first-in-class therapeutics aimed at promoting neurogenesis to improve outcomes for individuals suffering from neurological diseases. Their innovative approach targets specific signaling pathways to enhance the formation of new brain cells, with potential applications in condition... Read More
